Marx 1985 (ORN) + Bennett 2016 Cochrane support HBOT for late radiation tissue injury of head/neck and bowel.
Overview
HBOT is a UHMS-approved indication for delayed radiation injuries including osteoradionecrosis (ORN), radiation cystitis, radiation proctitis, and soft tissue radionecrosis. The mechanism involves angiogenesis stimulation in hypovascular, hypocellular, hypoxic (3H) tissue damaged by prior radiation therapy. Marx protocol (20 pre-op + 10 post-op sessions) is the gold standard for dental extractions in irradiated jaws.
How HBOT Works
HBOT reverses the 3H state through HIF-1α-driven angiogenesis. Intermittent hyperoxia stabilises HIF-1α in previously hypoxic tissue, triggering VEGF-mediated capillary growth. Over a 20–40 session course, measurable improvement in tissue vascularity and TcPO₂ develops. Enhanced neutrophil-mediated antimicrobial activity also addresses the chronic low-grade infection common in radionecrotic tissue.
Clinical Protocol
Typical protocol
20–40 sessions at 2.4 ATA, 90 minutes each
Evidence level
Strong — UHMS approved, Marx protocol validated
FDA / regulatory status
FDA-approved indication (Medicare coverage)
Marx prophylactic protocol: 20 sessions pre-op + 10 sessions post-op for dental extractions in irradiated mandible. Established radionecrosis: 30–40 sessions at 2.4 ATA. Radiation cystitis/proctitis: 20–40 sessions at 2.0–2.4 ATA (Clarke 2008 used 2.0 ATA / 30 sessions).
Cautions & Considerations
Course is long (30–40 sessions).
Does not reverse established tissue loss but prevents further breakdown and supports healing.
May require surgical intervention alongside HBOT (debridement, grafting).
Standard HBOT contraindications apply.
Key Research
Marx et al. 1985 (dental protocol)
Clarke et al. 2008 (radiation proctitis RCT)
Bennett et al. (Cochrane) 2016
UHMS Indications Manual
Indexed studies
Prevention of Osteoradionecrosis: A Randomized Prospective Clinical Trial of Hyperbaric Oxygen Versus Penicillin (1985, Level 1, 2.4 ATA) — PMID 3882848
Hyperbaric Oxygen Therapy for Late Radiation Tissue Injury (Cochrane Review) (2016, Level 1, 2.4 ATA) — PMID 27123955
Tenth European Consensus Conference on Hyperbaric Medicine (ECHM) (2017, Level 5) — PMID 28357821